BioVaxys Closes Final Tranche of Non-brokered Private Placement
VANCOUVER, BC, Feb. 28, 2022 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") is pleased to announce that it has closed the second and final tranche (the "Final Tranche") of its previously announced non-brokered private placement (the "Private Placement").
- VANCOUVER, BC, Feb. 28, 2022 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") is pleased to announce that it has closed the second and final tranche (the "Final Tranche") of its previously announced non-brokered private placement (the "Private Placement").
- Pursuant to Final Tranche of the Private Placement, the Company has issued 2,643,0333 units ("Units") at a price of $0.15 per Unit for gross proceeds of $396,500.
- Including the first tranche of the Private Placement which completed on February 10, 2022, the Company raised total aggregate gross proceeds of $798,500.
- All securities issued pursuant to Final Tranche of the Private Placement are subject to a statutory hold period of four months and one day from the date of issuance.